Dr. Peter Block and presenter Dr. Vera Bittner discuss lipoprotein(a) lowering by alirocumab contributes to total events reduction Independent of LDL (ODYSSEY OUTCOMES). Visit http://www.acc.org/ACC19 for full meeting coverage.